» Articles » PMID: 28380495

Risk Factors for Severe Reactions During Double-Blind Placebo-Controlled Food Challenges

Overview
Date 2017 Apr 6
PMID 28380495
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Severe anaphylactic symptoms can occur during oral food challenges (OFCs). Thus, high-risk patients (e.g., patients with a history of anaphylaxis or high antigen-specific immunoglobulin E [IgE] levels) must carefully undergo OFCs in hospitals. We attempted to identify the risk factors for severe symptoms during OFC testing among high-risk patients.

Methods: We retrospectively evaluated patients' characteristics and severe symptoms that were experienced during a double-blind placebo-controlled food challenge test performed before the patients underwent oral immunotherapy between June 2008 and June 2012. Patients were ≥5 years old and had an anaphylactic history or antigen-specific IgE (>30 kUA/L). Severe symptoms were defined using the grading of the Japanese Anaphylaxis Guidelines, which are modified from the European Academy of Allergology and Clinical Immunology Guidelines.

Results: We evaluated 393 cases with positive test results, including 98 cases with severe symptoms. The most frequent severe symptoms were respiratory (77%), gastrointestinal (28%), cardiovascular (27%), and neurological (13%) symptoms. Multivariate analysis revealed that the significant factors for a severe reaction were a history of anaphylaxis to the causative food (adjusted odds ratio [OR]: 2.147, p = 0.003), older age (per 1 year increase, adjusted OR: 1.102, p = 0.044), and an egg OFC (adjusted OR: 0.433, p = 0.003).

Conclusions: The risk factors for a severe reaction to OFCs were a history of an anaphylactic reaction and older age. An egg OFC was associated with low risk of severe symptoms during OFC. Therefore, OFCs for patients with these risk factors should only be performed under specialist supervision with access to rapid treatment and full resuscitation equipment.

Citing Articles

Milk ladder: Who? When? How? Where? with the lowest risk of reaction.

Buyuktiryaki B, Soyer O, Bingol G, Can C, Nacaroglu H, Bingol A Front Allergy. 2024; 5:1516774.

PMID: 39713044 PMC: 11659236. DOI: 10.3389/falgy.2024.1516774.


Oral food challenge test results of patients with food allergy with specific IgE levels >100 UA/ml.

Sasaki Y, Matsunami K, Kondo M, Matsukuma E, Imamura A, Kaneko H Biomed Rep. 2024; 21(6):178.

PMID: 39391782 PMC: 11464954. DOI: 10.3892/br.2024.1866.


Effect of Remimazolam on Emergence Delirium in Children Undergoing Laparoscopic Surgery: A Double-blinded Randomized Trial.

Cai Y, Zhong J, Ma H, Szmuk P, Wang C, Wang Z Anesthesiology. 2024; 141(3):500-510.

PMID: 38758221 PMC: 11323754. DOI: 10.1097/ALN.0000000000005077.


Differential diagnostics of food allergy as based on provocation tests and laboratory diagnostic assays.

Krzych-Falta E, Bialek S, Sybilski A, Tylewicz A, Samolinski B, Wojas O Postepy Dermatol Alergol. 2024; 40(6):709-715.

PMID: 38282888 PMC: 10809836. DOI: 10.5114/ada.2023.132501.


IgE-mediated cow's milk allergy in Brazilian children: Outcomes of oral food challenge.

Aquilante B, Castro A, Yonamine G, de Barros Dorna M, Barp M, Martins T World Allergy Organ J. 2023; 16(5):100781.

PMID: 37251812 PMC: 10209878. DOI: 10.1016/j.waojou.2023.100781.


References
1.
Ahrens B, Niggemann B, Wahn U, Beyer K . Organ-specific symptoms during oral food challenge in children with food allergy. J Allergy Clin Immunol. 2012; 130(2):549-51. DOI: 10.1016/j.jaci.2012.05.045. View

2.
Tan J, Campbell D, Turner P, Kakakios A, Wong M, Mehr S . Baked egg food challenges - clinical utility of skin test to baked egg and ovomucoid in children with egg allergy. Clin Exp Allergy. 2013; 43(10):1189-95. DOI: 10.1111/cea.12153. View

3.
Buelow B, Lee C, Zafra H, Dasgupta M, Hoffmann R, Vasudev M . Egg baked in product open oral food challenges are safe in selected egg-allergic patients. Allergy Rhinol (Providence). 2014; 5(2):110-2. PMC: 4124576. DOI: 10.2500/ar.2014.5.0092. View

4.
Sampson H . Anaphylaxis and emergency treatment. Pediatrics. 2003; 111(6 Pt 3):1601-8. View

5.
Komata T, Shukuya A, Imai T, Tachimoto H, Ebisawa M . [Single blind food challenge using dried food powder --2nd Report. milk]. Arerugi. 2009; 58(7):779-89. View